BuPROPion Hydrochloride 12 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet
1 INDICATIONS AND USAGE Bupropion hydrochloride extended-release tablets (SR) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM ) . The efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies ( 14 )] . The efficacy of bupropion in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see Clinical Studies ( 14 )] . Bupropion hydrochloride extended-release tablets (SR) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD). ( 1 )
Watson Laboratories, Inc.
ROUND WHITE WPI 839
WPI 839 ROUND WHITE
Related Pills
12 HR bupropion hydrochloride 100 MG Extended Release Oral Tablet
Actavis Pharma, Inc.
12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet
Aphena Pharma Solutions - Tennessee, LLC
12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet
Aphena Pharma Solutions - Tennessee, LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
BUPROPION HYDROCHLORIDE extended-release tablets USP (SR), 100 mg of
BUPROPION HYDROCHLORIDE, USP are white to off-white, round, unscored, bi-convex, film-coated tablets debossed with "WPI" over "858" on one side in bottles of 60 tablets (NDC 0591-3540-60) and 500 tablets (NDC 0591-3540-05).
BUPROPION HYDROCHLORIDE extended-release tablets USP (SR), 150 mg of
BUPROPION HYDROCHLORIDE, USP are white to off-white, round, unscored, bi-convex, film-coated tablets debossed with "WPI" over "839" on one side in bottles of 60 tablets (NDC 0591-3541-60), 250 tablets (NDC 0591-3541-25) and 500 tablets (NDC 0591-3541-05).
BUPROPION HYDROCHLORIDE extended-release tablets USP (SR), 200 mg of
BUPROPION HYDROCHLORIDE, USP are white to off-white, round, unscored, bi-convex, film-coated tablets debossed with "WPI" over "3385" on one side in bottles of 60 tablets (NDC 0591-3542-60). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture.
More pills like ROUND WPI 839